The ACC is enthusiastically backing the bipartisan legislation, saying it would improve care for the country's cardiovascular patients.

Percutaneous edge-to-edge mitral valve repair was associated with improved outcomes among TAVR patients with persistent mitral regurgitation. 

Though this does not seem to be a significant issue, the agency still recommends keeping consumer electronics at least six inches away from implanted medical devices.

“Our findings suggest that cardiologists should consider the value of regular psychological assessments, especially among younger patients,” one researcher said. The team's full findings will be presented at ACC.21. 

The authors evaluated data from more than 2.1 million patients, sharing their findings in Circulation.

This Class I recall covers more than 130,000 different devices, according to the FDA. 

Low levels of residual mitral regurgitation after TEER can make a big impact on patient outcomes, researchers explained in a new analysis. 

The company also announced that two specialists with more than 25 years of industry experience have joined its leadership team. 

Researchers called for better guidelines that cover when clinicians should consider stopping anticoagulation therapy for patients with AFib. The risks of such medication, they observed, may often outweigh the benefits. 

The full findings are scheduled to be presented May 16 at ACC.21.